rs117513345

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000520.6(HEXA):​c.759G>A​(p.Val253Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00498 in 1,614,144 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 26 hom. )

Consequence

HEXA
NM_000520.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.293
Variant links:
Genes affected
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 15-72350564-C-T is Benign according to our data. Variant chr15-72350564-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 256352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-72350564-C-T is described in Lovd as [Benign]. Variant chr15-72350564-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.293 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HEXANM_000520.6 linkc.759G>A p.Val253Val synonymous_variant Exon 7 of 14 ENST00000268097.10 NP_000511.2 P06865-1A0A0S2Z3W3
HEXANM_001318825.2 linkc.792G>A p.Val264Val synonymous_variant Exon 7 of 14 NP_001305754.1 P06865H3BP20B4DVA7
HEXANR_134869.3 linkn.801G>A non_coding_transcript_exon_variant Exon 7 of 11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HEXAENST00000268097.10 linkc.759G>A p.Val253Val synonymous_variant Exon 7 of 14 1 NM_000520.6 ENSP00000268097.6 P06865-1
ENSG00000260729ENST00000379915.4 linkn.413-4239G>A intron_variant Intron 3 of 15 2 ENSP00000478716.1 A0A087WUJ7

Frequencies

GnomAD3 genomes
AF:
0.00407
AC:
620
AN:
152200
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00603
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00628
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00458
AC:
1151
AN:
251480
Hom.:
10
AF XY:
0.00485
AC XY:
659
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00446
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00206
Gnomad FIN exome
AF:
0.00698
Gnomad NFE exome
AF:
0.00665
Gnomad OTH exome
AF:
0.00505
GnomAD4 exome
AF:
0.00508
AC:
7423
AN:
1461826
Hom.:
26
Cov.:
31
AF XY:
0.00513
AC XY:
3732
AN XY:
727208
show subpopulations
Gnomad4 AFR exome
AF:
0.000926
Gnomad4 AMR exome
AF:
0.00221
Gnomad4 ASJ exome
AF:
0.00402
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00210
Gnomad4 FIN exome
AF:
0.00614
Gnomad4 NFE exome
AF:
0.00574
Gnomad4 OTH exome
AF:
0.00432
GnomAD4 genome
AF:
0.00407
AC:
620
AN:
152318
Hom.:
5
Cov.:
32
AF XY:
0.00368
AC XY:
274
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000578
Gnomad4 AMR
AF:
0.00457
Gnomad4 ASJ
AF:
0.00403
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.00603
Gnomad4 NFE
AF:
0.00628
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00555
Hom.:
2
Bravo
AF:
0.00389
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00703
EpiControl
AF:
0.00711

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 19, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

May 16, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 05, 2016
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:4
Apr 30, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 19858779) -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

HEXA: BP4, BP7, BS2 -

Sep 12, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Tay-Sachs disease Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 25, 2017
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Apr 23, 2016
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.27
CADD
Benign
14
DANN
Benign
0.84
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117513345; hg19: chr15-72642905; COSMIC: COSV51507200; COSMIC: COSV51507200; API